Moneycontrol Presented by Motilal Oswal
Days hours minutes
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
Sep 14, 2017 03:44 PM IST | Source:

Buy Shree Pushkar Chemicals; target of Rs 245: ICICI Direct

ICICI Direct is bullish on Shree Pushkar Chemicals has recommended buy rating on the stock with a target price of Rs 245 in its research report dated September 14, 2017.

  • bselive
  • nselive
Todays L/H

ICICI Direct's research report on Shree Pushkar Chemicals

Shree Pushkar Chemicals & Fertilisers (SPCL) has announced the 100% acquisition of Kisan Phosphate Pvt Ltd (KPPL), operating in the fertiliser segment, in an all-equity swap deal The target company manufactures and operates in a segment similar to SPCL in Hisar, Haryana and is a promoter entity KPPL possesses a 1 lakh tonne single super phosphate capacity, 3000 tonne cattle feed capacity and 6000 tonne soil conditioner capacity. At optimum utilisation levels, the company can generate a topline of ~ Rs 60 crore. In FY17, net sales, EBITDA and PAT were at  Rs 35.7 crore,  Rs 5.4 crore (margins 15.4%) and  Rs 0.2 crore, respectively The deal values KPPL at ~ Rs 9.0 crore (equity value). It will be funded through a share swap agreement wherein KPPL shareholders will receive corresponding shares of SPCL. It is likely to result in a dilution of ~1.3% at the current market cap of SPCL (~ Rs 680 crore).


Acquisition of KPPL is a related party transaction (100% owned by promoters) done on an arm’s length basis, which is expected to be EPS accretive from FY19E onwards post the retirement of high costs debt & backward integration. Therefore, we retain our BUY rating on the stock with a target price of  Rs 245. We have not yet incorporated the financials of KPPL. We will wait for all regulatory approvals before incorporation of the same. The acquisition, being small (~1.3% equity dilution, ~9% of FY18E sales), will not drastically change the financials.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Follow us on
Available On